Table 5.
Univariate logistic regression assessing the association between patient characteristics and survival.
| OR | 95% CI | p-Value | |
|---|---|---|---|
| Age, years | 1.0268 | 0.9706 to 1.0863 | 0.36 |
| Gender (M/F) | 0.9529 | 0.2928 to 3.1016 | 0.94 |
| Smoking status, n (no/former/yes) | 1.3482 | 0.4379 to 4.1505 | 0.60 |
| Histological type, n (ADK/SQ) | 2.2917 | 0.5458 to 9.6219 | 0.26 |
| PD-L1, n (1–49%/<1%) | 1.1551 | 0.4030 to 3.3107 | 0.79 |
| Stage T, n (T1/T2/T3/T4) | 3.4877 | 0.6931 to 17.5496 | 0.13 |
| Stage N, n (N0/N1/N2/N3) | 2.0009 | 0.9653 to 4.1472 | 0.06 |
| Hb (g/dL) | 0.8804 | 0.6468 to 1.1982 | 0.42 |
| RDW, (%) | 1.1224 | 0.8410 to 1.4978 | 0.43 |
| WBC, n | 1.2202 | 1.0339 to 1.4400 | 0.019 |
| Neutrophils, n | 1.2916 | 1.0692 to 1.5604 | 0.008 |
| Lymphocytes, n | 0.5819 | 0.2719 to 1.2454 | 0.16 |
| Monocytes, n | 1.7055 | 0.2449 to 11.8784 | 0.59 |
| Platelets, n | 1.0014 | 0.9977 to 1.0052 | 0.45 |
| NLR | 1.3601 | 1.0949 to 1.6896 | 0.005 |
| NMR | 1.2159 | 1.0396 to 1.4221 | 0.015 |
| MLR | 5.6613 | 0.4789 to 66.9198 | 0.17 |
| PLR | 1.0023 | 0.9988 to 1.0058 | 0.19 |
| SII | 1.0004 | 1.0000 to 1.0007 | 0.054 |
| AISI | 1.0002 | 0.9999 to 1.0005 | 0.20 |
ADK: adenocarcinoma; AISI: aggregate index of systemic inflammation; F: female; Hb: hemoglobin; M: male; MLR: monocyte to lymphocyte ratio; NLR: neutrophil to lymphocyte ratio; NMR: neutrophil to monocyte ratio; PD-L1: programmed death ligand 1; RDW: red cell distribution width; SII: systemic inflammation index; SQ: squamous cell cancer; WBC: white blood cells.